CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. Between 74-89% of retail investor accounts lose money when trading CFDs. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money. Please refer to our Risk Disclosure Statement
Open platformOpen platform

Wave Life Sciences Q3 net loss widens 15% to $61.91 million; Q3 revenue rises 73% to $13.16 million

By Public Technologies
  • Wave Life Sciences’ third-quarter 2026 net loss widened 15% year over year to $61.91 million.
  • Revenue climbed 73% year over year to $13.16 million.
  • Cash, cash equivalents and marketable securities totaled $431 million at September 30, with operations funded into the third quarter of 2028.
  • Planning is underway for WVE-006’s two-year AATD registrational trial, including a one-year interim analysis supporting potential accelerated approval.
  • The WVE-007 combination trial with tirzepatide is underway, with a post-incretin maintenance trial targeted to begin in the fourth quarter of 2026.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Wave Life Sciences Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610270730PRIMZONEFULLFEED9853687) on October 27, 2026, and is solely responsible for the information contained therein.

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk